| abstract |
The present disclosure treats neurodegenerative diseases using a compound represented by the general formula (I) having c-abl kinase inhibitory activity or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing this compound, and this compound. Provide useful methods to prevent or prevent. |